VC funding drops for biotech, medical devices. Should we worry?

Venture capital investment in New England dropped 45 percent in the most recent quarter, largely due to fewer deals in biotechnology and medical devices. The national trend is down, too, though not as much, according to a new report from the National Venture Capital Association and PricewaterhouseCoopers. It’s definitely a challenge for the Boston area, [...]

Source: http://feedproxy.google.com/~r/HealthBusinessBlog/~3/9Q0zJfwlPtk/

anxiety medication blood pressure